Zahra Nafar was born in Iran, Tehran, where she received her B.S. degree in bioelectrical engineering. After working for an ophthalmic instrument company, she decided to continue her graduate education and obtained her Ph.D. in biomedical engineering with a focus on biomedical optics, ophthalmic imaging and vision science. She is now the Staff Concept Engineer for Ophthalmic Diagnostics Technology & Solutions Supervisory, at ZEISS Medical Technology in the US.

Patricia Sha, O.D. earned her Bachelor of Science in Biochemistry and Cell Biology from the University of California, San Diego. She then earned her Doctor of Optometry degree from the University of California, Berkeley, School of Optometry, where she was a part of the Beta Sigma Kappa Optometric Honor Society. After graduation, Patty practiced private eye care for 8 years in the Bay Area, CA and also became part of the Clinical and Algorithms team Carl Zeiss Meditec, Inc. She currently serves as Head of the Clinical Research team and performs numerous collaborations with key opinion leaders of the ophthalmic community with a special interest in OCT technology.

Tilman Schmoll obtained his PhD from the Medical University of Vienna, where he developed novel functional extensions of OCT for biomedical applications. He then joined Dublin’s Advanced Development Group, where he worked on innovative OCT systems and software. In 2018, he returned to the Medical University of Vienna and established the ZEISS Lab, a collaborative research lab that aims to advance the state-of-the-art in OCT technology and its clinical use.

Katharina Foote earned her Doctorate at the University of California, Berkeley in Vision Science with a focus on applied multi-modal retinal imaging techniques for patients with inherited retinal degenerations. She currently serves on the Advanced Technology & Concepts team at Carl Zeiss Meditec, where she leads the fundus imaging concept team.

Gwen Musial received her Doctorate of Philosophy in Biomedical Engineering at the University of Houston with a primary area of research in advanced imaging with applications to glaucoma. Prior to joining ZEISS, she was the Primary Investigator at the Cologne Experimental Eye Imaging Center at the University of Cologne.

Dirk Seidel received his PhD in quantum optics at the Göttingen University in Germany, and later completed his PostDoc in Quantum and Atom Optics in Bilbao, Spain. Dirk is a proud Zeissian since 2006. He initially joined ZEISS as a Senior System Engineer for the Semiconductor Mask Solutions strategic business unit in Jena, Germany, where he worked for the development of photomask metrology solutions and lithography simulations. Since 2018, he started working as a Research Scientist for Carl Zeiss AG in optical simulations and virtual prototyping, model-based metrology and learning-based simulations. Dirk has 14 publications and 30 patents for ZEISS.

In 2003, Arne Ohlendorf concluded his three-year training as an ophthalmic optician. In 2007, Arne completed his course of study in “Optometry and Vision Science” at the University of Applied Sciences in Jena, Germany, and in 2011 he got his PhD from the University Tübingen. After getting his PhD, Arne joined ZEISS Vision Care in Aalen, Germany, in the Technology and Innovation field. In 2013, he was part of the ZEISS Vision Science Lab, an “Industry on Campus Professorship” workgroup at the University of Tübingen. Since 2018, he is working as a Staff Scientist at ZEISS Vision Care.

Philippe Maury joined ZEISS as Senior Market Development Manager in 2020 and was then appointed as Head of Product Management Therapeutic Lasers. Before joining ZEISS, Philippe was General Manager of Ellex EMEA since 2011. He previously served as EMEA sales manager and marketing manager at Ellex with a specific focus on the introduction of new laser therapies and more recently 2RT (AMD). From 2000 to 2006, Philippe was project manager at Quantel Medical and was in charge of the ultrasound imaging and therapeutic lasers product lines. Philippe Maury studied physics and business administration at Saint Jérôme University and ESC Marseille.

Devon Kennedy received her Doctorate of Optometry at the Southern California College of Optometry with a primary area of interest in anterior segment disease and surgical co-management. Prior to joining ZEISS, she practiced in a high-volume premium refractive and cataract surgery center while serving as adjunct clinical faculty for multiple optometry schools. She is the US Lead for Optometric Market Development in Refractive Surgery Co-Management.